12 reasons U.S. healthcare costs more than in other countries

The United States spends more on healthcare than any other wealthy country, but Americans are not necessarily receiving more care. Data from KFF and the Peterson-KFF Health System Tracker show that U.S. healthcare spending has remained around 18% of the economy in recent years. Many comparable countries spend between 10% and 12%, and the amount spent per person in the U.S. is nearly twice the average among other wealthy nations.

That difference reaches far beyond government budgets. It appears in rising insurance premiums, large deductibles, medical debt, surprise bills, and people delaying treatment because they cannot afford it. Americans generally do not visit doctors or stay in hospitals far more often than people elsewhere. The country simply pays much higher prices for nearly every part of the healthcare experience.

The U.S. Pays Much Higher Prices for Care

Healthcare is more expensive in America largely because hospitals, doctors, drug companies, and other providers charge more for their services. A major JAMA comparison of the U.S. with other high-income countries found that higher prices for labor, hospital care, and medical goods were the main reasons for the spending gap. Greater use of medical services played a much smaller role.

Those prices eventually reach patients, even when an insurance company pays the original bill. Insurers respond by raising premiums, deductibles, and other out-of-pocket costs. Many other countries use national negotiations or regulated fee schedules to limit what providers can charge. The U.S. has no comprehensive system for controlling prices across the entire healthcare market.

Prescription Drugs Cost Much More

Prescription medicines offer one of the clearest examples of America’s pricing problem. JAMA analyses have placed U.S. pharmaceutical spending at roughly $1,443 per person each year. Spending in many comparable countries ranges from about $466 to less than $1,000 per person.

Americans are not necessarily using twice as many medicines. They are often paying much more for the same products, especially brand-name drugs. Purchasing is divided among private insurers, government programs, pharmacies, and pharmacy benefit managers, with each participant negotiating its own arrangements. The result can be high copays and inflated list prices that lead some patients to skip doses, split pills, or leave prescriptions unfilled.

Administrative Costs Are Exceptionally High

The American healthcare system spends an unusually large amount on billing, insurance operations, claims, and paperwork. The JAMA comparison estimated that administration accounts for about 8% of total U.S. healthcare spending. In many similar countries, the share is closer to 1% to 3%.

Doctors and hospitals must work with thousands of insurance plans, each with different networks, billing codes, coverage rules, and approval requirements. That means hiring large teams to handle prior authorizations, denied claims, appeals, and contracts. The Commonwealth Fund has estimated that administrative expenses can consume 15% to 30% of hospital spending. Patients ultimately help pay for that bureaucracy, even though it does little to improve their health.

Clinician Wages and Labor Costs Are Higher

Doctors, nurses, and other healthcare workers generally earn more in the U.S. than their counterparts in similar countries. JAMA Health Forum study found that American generalist physicians earn around $218,000 a year, compared with roughly $86,000 to $154,000 in several peer nations. Specialists in the U.S. also tend to earn substantially more.

There are understandable reasons for the difference, including long training periods, costly medical education, malpractice concerns, and student debt. Still, higher wages make every appointment, procedure, and hospital stay more expensive. Other countries often negotiate salaries and payment rates through national systems. In America, powerful hospital groups and specialist practices can privately negotiate much higher rates with insurers.

The System Favors Expensive Technology

American healthcare embraces advanced medical technology quickly, including MRI machines, CT scanners, robotic surgery, and complex cardiac procedures. Peterson-KFF comparisons show that the U.S. uses some forms of advanced imaging more frequently than many peer countries. These technologies can save lives, but they also come with high purchase, maintenance, and operating costs.

The problem arises when expensive technology is used even though a simpler option might work just as well. Other countries often rely on national agencies to study whether a new procedure provides enough benefit to justify its cost. The U.S. usually adopts new technology faster and reimburses providers generously for using it. That can increase spending without producing an equally large improvement in public health.

Fee-for-Service Rewards More Treatment

Much of American healthcare still operates under a fee-for-service model. Providers receive payment for each consultation, test, scan, treatment, and procedure they perform. More billable activity therefore produces more revenue, even when additional care offers only a small benefit.

Many peer countries rely more heavily on global hospital budgets, regulated payment schedules, or fixed payments for managing a patient’s care. These models reduce the financial pressure to keep ordering more services. The U.S. has experimented with bundled payments and accountable care organizations, but fee-for-service remains deeply rooted. As long as doing more means earning more, healthcare spending will remain difficult to control.

Care Is Often Fragmented

American patients frequently receive care from several providers who do not work together or share information effectively. Someone with a chronic condition may see a primary care doctor, multiple specialists, a hospital team, and an outside laboratory. When communication breaks down, patients may receive duplicate tests, conflicting medications, or treatment plans that do not fit together.

Countries with strong primary care systems usually give one medical team responsibility for coordinating most of a patient’s treatment. That approach can prevent complications and reduce unnecessary hospital visits. Some integrated U.S. health systems work this way, but many patients still move through a patchwork of disconnected offices. Changing insurers or losing coverage can make that fragmentation even worse.

Powerful Providers Can Demand Higher Prices

Most wealthy countries set or negotiate healthcare prices at a national or regional level. The U.S. largely allows hospitals and insurers to negotiate rates privately. As a result, the price of the same procedure can vary dramatically between hospitals, cities, and insurance plans.

Hospital consolidation has made this problem more serious. When one large health system controls much of a local market, insurers may have little choice but to accept its prices. Those higher rates are then reflected in premiums and patient bills. Limited competition, weak price regulation, and uneven antitrust enforcement allow powerful providers to charge far more than similar facilities in other countries.

Private Insurance Adds More Overhead

Private health insurance plays a larger role in the U.S. than it does in most comparable healthcare systems. JAMA study estimates that about 55.3% of Americans receive coverage through private insurance. Many other countries rely more heavily on public financing or closely regulated nonprofit insurance funds.

Private insurers spend money on marketing, benefit design, provider networks, claims reviews, and prior authorization systems. These activities may help an individual company control risk, but they add complexity to the healthcare system as a whole. Hospitals and doctors must then spend more money responding to each insurer’s requirements. Countries with standardized benefits and centralized financing usually operate with much lower overhead.

Americans Carry a Heavy Chronic Disease Burden

The U.S. population has high rates of obesity, diabetes, heart disease, and other chronic illnesses that require long-term treatment. Roughly 70% of American adults were classified as either overweight or obese, a higher share than in many comparable countries. Managing these conditions often involves regular appointments, medications, laboratory tests, and hospital care.

Greater medical need explains part of America’s spending, but it does not explain the entire gap. The U.S. still has a lower life expectancy and higher rates of avoidable death than many countries that spend far less. Other nations often invest more consistently in prevention, primary care, and social support. America frequently pays for expensive treatment after a condition has already become severe.

Too Much Money Goes Toward Low-Value Care

Healthcare spending often rises sharply during the final year of a person’s life. American patients may experience repeated hospitalizations, intensive care stays, and aggressive treatments that offer little improvement in survival or comfort. Financial incentives, malpractice fears, and cultural expectations can all encourage doctors and families to continue treatment.

Waste is not limited to end-of-life care. Researchers have identified many tests, medications, and procedures that provide little benefit to most patients in certain situations. Programs such as Choosing Wisely have tried to reduce these services, but low-value care still costs the country tens of billions of dollars. Countries with stronger national guidelines and tighter payment rules have generally been more successful at limiting unnecessary treatment.

The Patchwork System Weakens Cost Control

America did not build one unified healthcare system. It created a collection of employer plans, private insurance markets, Medicare, Medicaid, veterans’ programs, and safety-net services. Each part has its own rules, payment methods, and eligibility requirements.

This patchwork leaves millions of people uninsured or with coverage that still exposes them to large bills. Some delay routine care until a medical problem becomes serious enough to require emergency treatment or hospitalization. Fragmented financing also weakens the country’s ability to negotiate prices and standardize benefits. Until the U.S. decides to treat healthcare more like a coordinated essential service, controlling costs will remain extraordinarily difficult.

Disclaimer – This list is solely the author’s opinion based on research and publicly available information. It is not intended to be professional advice.

Like our content? Be sure to follow us.